Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2010
05/06/2010US20100112090 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
05/06/2010US20100112056 Immediate release dosage forms of sodium oxybate
05/06/2010US20100112053 Gastric retention-type sustained-release levodopa preparation
05/06/2010US20100112051 Tianeptine sulfate salt forms and methods of making and using the same
05/06/2010US20100112050 Dosage Form For Insertion Into The Mouth
05/06/2010US20100112048 Dosage Regimen and Medicament For Reducing Risk of Onset or Progression of Dementia by Administration of Specific Vitamins and Nsaid
05/06/2010US20100112047 Omega 3 fatty acid formulations
05/06/2010US20100112045 Surface-treated modafinil particles
05/06/2010US20100112038 Methods of treating neurological conditions with hematopoeitic growth factors
05/06/2010US20100112014 Novel hydrogel compositions and methods of using
05/06/2010US20100111972 Method for preventing or treating opiate tolerance and dependence
05/06/2010US20100111971 Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases
05/06/2010US20100111929 Method of treating peripheral nerve disorders
05/06/2010US20100111926 Method of Using Salmon Thrombin to Alleviate Central Nervous System-Mediated Pain
05/06/2010US20100111922 Animal model and use of 17beta-hydroxysteroid dehydrogenase type 7 in the diagnosis of anencephaly
05/06/2010US20100111918 Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring
05/06/2010US20100111913 Method of enhancing migration of neural precursor cells
05/06/2010US20100111876 Use of metal nanoparticles in the diagnosis of alzheimer's disease
05/06/2010US20100111862 Radiolabelled inhibitors of the glycine 1 transporter
05/06/2010US20100111853 Antibodies that bind to il-12 and methods of purifying the same
05/06/2010US20100111838 Brain-localizing polypeptides comprising a multivalent binding moiety and improved metabolic stability
05/06/2010US20100108059 Directional use
05/06/2010CA2742322A1 Azepino[4,5-b]indoles and methods of use
05/06/2010CA2742320A1 Pyrido[4,3-b]indoles containing rigid moieties
05/06/2010CA2741709A1 Substituted spiroamines
05/06/2010CA2741668A1 Novel substituted azabenzoxazoles
05/06/2010CA2741661A1 Novel amide derivative and use thereof as medicine
05/06/2010CA2741658A1 Piperidine derivative, piperazine derivative and agent for treatment of disease involving central nervous system disorders
05/06/2010CA2741646A1 Cyclohexylamine derivative containing phenyl group, and therapeutic agent for disease accompanied by central nervous system disorders
05/06/2010CA2740058A1 An antidiabetic agent
05/06/2010CA2739883A1 Cyclohexane derivative and pharmaceutical use thereof
05/06/2010CA2738776A1 7-azaspiro [3.5] nonane-7-carboxamide compounds as modulators of fatty acid amide hydrolase
05/06/2010CA2643496A1 The therapeutic use of igg as a neuroprotective agent
05/05/2010EP2181992A1 Polycyclic compound
05/05/2010EP2181709A1 Synergic combination of analgesic compounds
05/05/2010EP2181708A1 Use of Valproate for reducing CHOP levels, particularly in a mammal having SCI
05/05/2010EP2181091A2 Amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
05/05/2010EP2180899A2 Cytoplasmic malate dehydrogenase (mdh1) targeted treatment for neurodegenerative diseases
05/05/2010EP2102204B1 New aminopyrrolo[1,2- a]indole et aminopyridazino[1,6-a]indole derivatives, method for preparing the same and pharmaceutical compositions containing the same
05/05/2010EP1987001B1 1-phenethylpiperidine derivatives and their use as opioid receptor ligands
05/05/2010EP1957452B1 Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-b,b-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-hept anoic acid magnesium
05/05/2010EP1948648B1 3-aryl-isoxazole-4-carbonyl-benzofurane derivatives
05/05/2010EP1615914B1 Cgrp receptor antagonists
05/05/2010EP1485081B1 Ibuprofen solution for hard shell capsules
05/05/2010EP1474147B1 Pyrimidine-based compounds useful as gsk-3 inhibitors
05/05/2010EP1472240B1 Drechslera anole derivatives, method for the production and use thereof
05/05/2010EP1461054B1 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
05/05/2010EP1425026B1 Valeriana officinalis extract for treating sleep-induced apnea or hypopnea
05/05/2010EP1417206B1 Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
05/05/2010EP1248803B1 Nogo receptor-mediated blockade of axonal growth
05/05/2010CN1993120B Arylacetic acids and related compounds for treatment of alzheimer's disease
05/05/2010CN1947767B Medicine for treating and preventing infantile mental retardation, and its preparation method
05/05/2010CN1875968B Application of anisodamine in preparation of smoking-stopping medicament
05/05/2010CN1816353B Medicinal composition for preventing or treating Th1 type immunological disease
05/05/2010CN1813740B Sublingual pellicles containing naloxone hydrochloride and preparing method thereof
05/05/2010CN1787820B Composition for improving cognition and memory
05/05/2010CN1764661B Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain.
05/05/2010CN1726037B Treatment of headache with antipsychotics delivered by inhalation
05/05/2010CN1713911B Medicament component of berberine for the use of prevention and treatment of psycological dependence on and analgesic tolerance to morphine
05/05/2010CN1663600B Compound preparation composed of ginkgo leaf extracts and medicines promoting cerebral metabolism and its application
05/05/2010CN1649569B Controlled release dosage forms
05/05/2010CN1630526B Systems and methods for treating patients with processed lipoaspirate cells
05/05/2010CN1416341B Stable emulsion compositions
05/05/2010CN101701218A Immune regulatory oligodeoxynucleotide for inhibiting differentiation of Th1 and Th17 and application thereof
05/05/2010CN101701032A Quinoxalinone low molecular weight peptide derivative with matrix metalloproteinases inhibition function and preparation method and application thereof
05/05/2010CN101701006A Phenethanolamine derivatives for treatment of respiratory diseases
05/05/2010CN101700398A Traditional Chinese medicine decoction for antialcoholism
05/05/2010CN101700385A Pharmaceutical composition medicinal liquor or tincture for curing white vein disease and preparation method thereof
05/05/2010CN101700373A Traditional Chinese medicine used for smoking cessation
05/05/2010CN101700345A Oral traditional Chinese medicine composition for treating migraine
05/05/2010CN101700336A Chinese herba preparation for curing craniocerebra trauma residual headache
05/05/2010CN101700330A Traditional Chinese medicinal capsules for treating schizophrenia
05/05/2010CN101700311A Method for producing lozenge capable of tonifying qi and soothing nerves
05/05/2010CN101700304A Method for controlling quality of circulation plus decoction oral liquid
05/05/2010CN101700294A Oral traditional Chinese medicine decoction for treating migraine
05/05/2010CN101700271A Traditional Chinese medicine preparation for treating apoplexy sequelae
05/05/2010CN101700270A Traditional Chinese medicine composition used for neurasthenia and preparation method and quality control method thereof
05/05/2010CN101700268A Liver protection soft capsules
05/05/2010CN101700264A Application of pseudo-ginseng and extract thereof in preparing medicament for curing and/or preventing diabetic neuropathies
05/05/2010CN101700263A Method for preparing acer truncatum buge oil microemulsion
05/05/2010CN101700260A Purslane seed polysaccharide granule preparation and preparation method thereof
05/05/2010CN101700255A Compound fermentation glossy ganoderma capsule and preparation method thereof
05/05/2010CN101700230A Monosialote rahexosylganglioside microsphere and preparing method thereof
05/05/2010CN101700226A Naltrexone long-acting sustained-release preparation with no need of coating and preparation method thereof
05/05/2010CN101700224A Method for preparing oral chondroitin sulfate nanoemulsion
05/05/2010CN101060847B Loxapine analogs and methods of use thereof
05/05/2010CN101056859B Quinoline derivatives as isotope labeling for adenosine a3 receptor ligand
05/05/2010CN101035550B Composition and method for therapy or prevention of mental symptom
05/05/2010CN101035533B Dual NK1/NK3 antagonists against schizophrenia
05/05/2010CN101031298B Medicine with analgesic function
05/05/2010CN101022817B Therapeutic or preventive agent for diabetic neuropathy
05/04/2010USRE41315 Modulators of dopamine neurotransmission
05/04/2010US7709664 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia
05/04/2010US7709535 Androgen receptor antagonists; certain cancers such as colon, skin and prostate cancer, baldness, hirsutism, behavioral disorders, acne, and inhibition of spermatogenesis if so desired
05/04/2010US7709523 Alpha-aminoamide derivatives useful as antimigraine agents
05/04/2010US7709515 Therapy for cardiovascular disorders; dyslipidemia; glucose metabolism disorders; Alzheimer's disease
05/04/2010US7709514 benzimidazole-2-one-5-n-pentanoate; inhibiting Macrophage Migration Inhibitory Factor (MIF); rheumatoid arthritis
05/04/2010US7709506 Kinase inhibitors to mediate disease and as antiinflammatory agents
05/04/2010US7709500 Chemical compounds
05/04/2010US7709489 e.g. 1-(9-Benzylamino-10-cyano-imidazo[1,2-a]quinoline-2-carbonyl)-4-methylpiperazine; cardiovascular diseases; acylation of imidazo[1,2- alpha]quinoline acid derivatives by morpholine derivatives